Investigational drug · Phase 2
ABCL635
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Vasomotor Symptoms Associated With Menopause, Healthy Volunteers.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "ABCL635"
First trial start
2025
Jun 23, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ABCL635", any sponsor or status.
Conditions studied
As listed on its trial records.
- Vasomotor Symptoms Associated With Menopause
- Healthy Volunteers
Approved drugs for the same conditions: Menopause symptoms · Endocrinology and women's health
Largest trials
Live from ClinicalTrials.gov: studies naming "ABCL635" as an intervention, largest first.
- Study Evaluating ABCL635 for Vasomotor Symptoms of MenopausePivotal-lookingActive, not recruiting
AbCellera Biologics Inc.Industry
NCT07118891 · 136 participants (planned) · Start Jun 23, 2025 · Primary completion Feb 2027
Drug: ABCL635; Placebo · For: Vasomotor Symptoms Associated With Menopause; Healthy Volunteers
Sites: Calgary, Canada; Red Deer, Canada; Vancouver, Canada · 13 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.